LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Summit Therapeutics Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERSMMT
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / SMMT COVERAGE

What’s moving Summit Therapeutics Inc. now

Current reporting with the operating signal separated from the noise.

01
TradingKey

Summit Therapeutics Inc (SMMT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

The story matters when it changes Summit Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
TradingKey

Summit Therapeutics Inc (SMMT) Valuation: PE, PB & Fair Value Analysis

The development tests whether Summit Therapeutics Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
03
TradingKey

Summit Therapeutics Inc (SMMT) Institutional Confidence

The story matters when it changes Summit Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
TradingKey

Summit Therapeutics Inc (SMMT) Financial Health: Profitability & Balance Sheet Analysis

Investors are testing whether Summit Therapeutics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Morningstar

Kuehn Law Encourages Investors of Summit Therapeutics Inc. to Contact Law Firm

The story matters when it changes Summit Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest SMMT filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-07-23 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-04-30 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-23 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-23 · Period 2026-07-23SEC ↗8-KMaterial company eventFiled 2026-07-23 · Period 2026-07-23SEC ↗8-KMaterial company eventFiled 2026-07-22 · Period 2026-07-22SEC ↗6-KOfficial SEC filingFiled 2020-09-17 · Period 2020-09-17SEC ↗6-KOfficial SEC filingFiled 2020-08-19 · Period 2020-08-19SEC ↗
EARNINGS / QUARTERLY TRACKER

Summit Therapeutics Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.